Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 4 months ago
Share
Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areata
30 patients around the world
Available in
Mexico
Universidad Autonoma de Nuevo Leon
1
Research sites
30
Patients around the world
This study is for people with
Alopecia
Alopecia areata
Requirements for the patient
From 6 Years
All Gender
Medical requirements
Inclusion criteria
Diagnosis of alopecia areata.
SALT score of less than 50% extension.
Has not received any topical or systemic treatment in the last month.
Signed informed consent.
Exclusion criteria
Any skin condition on the scalp (infectious, inflammatory or neoplastic) that could modify the clinical of trichoscopic features.
Pregnancy or breast-feeding.
Patients in medications that could cause hair loss as side-effects.
Sites
Hospital Universitario Dr. José Eleuterio González
Recruiting
Consult
View site
Av. Dr. José Eleuterio González, Mitras Centro, 64460 Monterrey, N.L., Mexico
View site
Consult
See details
Contact us
Contact us
Sponsor
Universidad Autonoma de Nuevo Leon
Conditions
Alopecia areata
Requirements
From 6 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT06564805
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent